Back to EYPT

EyePoint Pharmaceuticals, Inc. 10-Q

Accession 0001193125-18-323795

Filing information

CIK
0001314102
Report date
2018-09-30
Filing date
2018-11-09
Form
10-Q
Primary document
d635570d10q.htm

Open primary document

View the filing document on sec.gov.

Open EDGAR directory

Inspect all files for this filing.

Complete submission file

Open the raw SEC submission text.